Amgen Achieves A First With European Eculizumab Nod

Bekemv Biosimilar Rival To Soliris Receives Positive Opinion From EMA’s CHMP

 
• By David Wallace
EMA
The EMA’s CHMP has endorsed Amgen’s eculizumab rival

More from Biosimilars

More from Products